Clinical Research Malaysia’s Post

🌍 Why South Korea for Your Clinical Trials? Seeking a place where innovation meets efficiency in clinical research? South Korea is leading the way with rapid approvals, advanced healthcare infrastructure, and a skilled research workforce. From faster trial timelines to high-quality data, it's the ideal destination for cutting-edge studies. 🌏 Find out how South Korea can accelerate your next clinical trial and deliver impactful results. 👇 https://lnkd.in/gXjS3yS7 #ClinicalTrials #PharmaResearch #GlobalHealthcare #DrugDevelopment

Missed the Outsourcing in Clinical Trials & Clinical Trial Supply East Asia Conference in Seoul in December? Check out key insights from HiRO CEO Karen Chu on why Korea is a prime destination for clinical research. With its high-standard medical infrastructure and efficient patient enrolment, Korea is an important market for cross-border clinical trials. Learn more in the video below. #HiRO #OCTCTSEastAsia #ClinicalResearch #KoreanMarket #BiotechInnovation

📢 Valuable Reports and Documents Alert! 🌟 I would like to share a fantastic resource for anyone interested in the clinical trial landscape in Korea. The Korea National Enterprise for Clinical Trials (KONECT) offers a wealth of valuable reports on various topics related to clinical studies in Korea, and these reports are freely available for download! 📑🔍 You can explore these insightful reports and stay updated on the latest clinical trial status by visiting the following link: KONECT Library. Whether you are a researcher, healthcare professional, or simply interested in the advancements in clinical research of Korea, these reports are an excellent resource to deepen your understanding and stay informed. Don't miss out on this opportunity to access high-quality information and enhance your knowledge about clinical trials in Korea! Documents and reports are availabe in English version as well!💡 Those reports provide a wide range of statistical data that allows you to understand the current status and future prospects of the clinical trials market in Korea through the latest information and predictions. https://lnkd.in/gM5CwTmG #ClinicalTrials #Korea #KONECT #HealthcareResearch #MedicalInnovation #ClinicalResearch #Healthcare #CNRResearch #SouthKoreaClinicalTrials #GlobalClinicalTrials #GlobalCRO #씨엔알리서치 #국가임상시험지원재단 #글로벌임상시험 #보고서 #임상시험현황 #한국임상시험

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/gSEw2yqY

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://buff.ly/3OeUA3a

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/gZPRdsFt

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. https://lnkd.in/g8RHKVjb 👉 Contact @Credevo for conducting clinical trials in Japan

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/gT_mCpRr

JAPAN CLINICAL TRIALS Why choose #Japan for conducting clinical trials? Explore its state-of-the-art medical facilities, rigorous regulatory standards, world-class scientific expertise, and captivating cultural heritage. #ClinicalTrials #ResearchInJapan #pmda Click on the link below to discover why you should choose Japan for your clinical trials and learn about the regulatory process for conducting clinical trials in Japan. 👉 Contact @Credevo for conducting clinical trials in Japan https://lnkd.in/g2pMkYYS

很充实的2023年年终。很高兴受世界中医药联合会邀请成为他们第五届理事会的常务理事。 我同时受邀出席在上海 国际标准化论坛代表新加坡做了一个主旨演讲《中医药国际传播与立法 与新加坡为例》。同时被聘请为世中联标准建设委员会的副会长。我也代表新加坡出席了上海世界传统医学大会帮忙制定了《上海倡议》。 A very fruitful end to the year 2023. I am glad to be invited by the World Federation of Chinese Medicine Societies (WFCMS) to become the Executive Director of their fifth Executive Council. I was also invited to attend the International Standardization Forum in Shanghai to deliver a keynote speech representing Singapore, "International transmission and Legislation of TCM - The Singapore Story". Additionally, I was appointed as the Vice President of the Standard Construction Committee of the WFCMS. I also represented Singapore at the Shanghai World Traditional Medicine Forum and assisted in drafting the "Shanghai Initiative."